The Royal Marsden NHS Foundation Trusts
Purchase of AAA Netspot - 40 microgram kit for Radio-Pharmaceutical preparation
This is a contract result notice, not an open opportunity. Details from the official award data.
This sits in the upper-middle of the Medical Equipment & Pharmaceuticals band — a substantial contract for the sector. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.
The Royal Marsden Hospital NHS Foundation Trust had to purchase Netspot (gallium Ga 68 dotatate) which is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumours.
Netspot (gallium Ga-68 dotatate) is a somatostatin analogue which demonstrates excellent uptake and in vivo stability rapid, tissue penetration, binding and clearance are observed and as a result the speed and resolution of picture acquisition is improved and the patient receives a much lower radiation dose.
Use of Ga-68 generator also enable production of Ga-68 PSMA on-site allowing flexibility of service and negates reliance on outsourced companies for delivery radiopharmaceuticlals.
As the vial is multidose the Trust currently has a high throughput of patients who are prescribed this scan, failure to order in the quantities required results increased waiting lists and delays to the service.
This product is licensed in USA but unlicensed in UK.
It can only be sourced in the UK from Imaging Equipment Ltd.
There is no other available treatment as effective available on the NHS - Ga-68 dotatate scan can be used in PET imaging.
PET imaging provides greater resolution and speed of imaging and therefore diagnosis of neuroendocrine tumours.
What the supplier must deliver
Netspot (gallium Ga-68 dotatate) is a somatostatin
Netspot (gallium Ga-68 dotatate) is a somatostatin analogue which demonstrates excellent uptake and in vivo stability rapid, tissue penetration, binding and clearance are observed and as a result the speed and resolution of picture acquisition is improved and the patient receives a much lower radiation dose.
Derived from the notice text — always confirm against the original documents.
Make the case to bid
Reveal who to approach at The Royal Marsden NHS Foundation Trusts, and generate a go-to-market strategy from their news, accounts and people.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- e5c28c73-a7bb-4fbd-baa1-e1e4f493f431
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- CHELWEST-DN405224-11220669
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
The Royal Marsden NHS Foundation Trusts’s tender network
Assembling the network…